On Friday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) opened higher 11.80% from the last session, before settling in for the closing price of $6.61. Price fluctuations for CRVS have ranged from $2.54 to $10.00 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 8.47% over the past five years. Company’s average yearly earnings per share was noted 63.24% at the time writing. With a float of $54.39 million, this company’s outstanding shares have now reached $74.51 million.
Corvus Pharmaceuticals Inc (CRVS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Corvus Pharmaceuticals Inc is 27.01%, while institutional ownership is 36.89%. The most recent insider transaction that took place on Jun 27 ’25, was worth 4,891,894. In this transaction Director of this company sold 1,176,332 shares at a rate of $4.16, taking the stock ownership to the 7,165,006 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Director sold 1,176,332 for $4.16, making the entire transaction worth $4,891,894. This insider now owns 7,165,006 shares in total.
Corvus Pharmaceuticals Inc (CRVS) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.6 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.12) by -0.48. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.52% during the next five years compared to 8.47% growth over the previous five years of trading.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Trading Performance Indicators
Check out the current performance indicators for Corvus Pharmaceuticals Inc (CRVS). In the past quarter, the stock posted a quick ratio of 8.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.02, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Corvus Pharmaceuticals Inc (CRVS)
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) saw its 5-day average volume 0.72 million, a negative change from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 96.10%.
During the past 100 days, Corvus Pharmaceuticals Inc’s (CRVS) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.37 in the past 14 days, which was higher than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.27, while its 200-day Moving Average is $4.60. Nevertheless, the first resistance level for the watch stands at $7.67 in the near term. At $7.96, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.52. If the price goes on to break the first support level at $6.82, it is likely to go to the next support level at $6.26. The third support level lies at $5.97 if the price breaches the second support level.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Key Stats
There are currently 74,514K shares outstanding in the company with a market cap of 550.66 million. Presently, the company’s annual sales total 0 K according to its annual income of -62,290 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -8,000 K.
